NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
1.190
+0.040 (3.48%)
Jan 3, 2025, 4:00 PM EST - Market closed

NeuroSense Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Cash & Equivalents
0.342.643.5411.060.70.9
Short-Term Investments
--3.55---
Cash & Short-Term Investments
0.342.647.0911.060.70.9
Cash Growth
-92.77%-62.76%-35.91%1482.69%-21.90%-
Other Receivables
0.410.170.130.180.030.02
Receivables
0.410.170.130.180.030.02
Prepaid Expenses
-0.070.120.13--
Other Current Assets
0.040.040.040.040.04-
Total Current Assets
0.792.927.3811.410.770.91
Property, Plant & Equipment
0.180.250.310.020.010.01
Other Long-Term Assets
0.020.020.02--0.04
Total Assets
0.983.197.7211.430.780.96
Accounts Payable
1.391.460.50.040.060.02
Accrued Expenses
-1.931.160.560.070.01
Current Portion of Leases
-0.070.06---
Total Current Liabilities
3.783.461.730.60.120.04
Long-Term Leases
0.020.070.15---
Other Long-Term Liabilities
-1.41-1.83--
Total Liabilities
3.84.941.872.430.120.04
Additional Paid-In Capital
31.7124.3621.8617.455.062.5
Retained Earnings
-34.53-26.12-16.01-8.45-4.41-1.58
Shareholders' Equity
-2.82-1.765.849.010.660.92
Total Liabilities & Equity
0.983.197.7211.430.780.96
Total Debt
0.020.140.21---
Net Cash (Debt)
0.332.56.8811.060.70.9
Net Cash Growth
-93.05%-63.69%-37.82%1482.69%-21.90%-
Net Cash Per Share
0.020.180.601.770.130.19
Filing Date Shares Outstanding
19.8115.3811.7910.945.824.63
Total Common Shares Outstanding
19.8115.3811.7810.945.584.63
Working Capital
-3-0.545.6610.820.650.88
Book Value Per Share
-0.14-0.110.500.820.120.20
Tangible Book Value
-2.82-1.765.849.010.660.92
Tangible Book Value Per Share
-0.14-0.110.500.820.120.20
Machinery
-0.120.090.020.010
Leasehold Improvements
-00-0.010
Source: S&P Capital IQ. Standard template. Financial Sources.